HER2+ | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

5,468 results for “HER2+”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Evaluation of HER2DX Assay on Treatment Decisions in Patients With Early Stage HER2+ Breast Cancer: the HER2BREASTDX

60 participants · First posted Dec 9, 2024

BATs in Patients With Breast Cancer and Leptomeningeal Metastases

3 participants · First posted Sep 7, 2018

TAC T-cells for the Treatment of HER2-positive Solid Tumors

28 participants · First posted Jan 27, 2021

Phase II Trial of Anti-HER2 Treatment in HER2-enriched Early Breast Cancer Identified by PAM50 (HER2E-PAM, PAMILIA Study)

59 participants · First posted Mar 26, 2021

Active, not recruiting

Her2-BATS and Pembrolizumab in Metastatic Breast Cancer

33 participants · First posted Sep 5, 2017

A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer

8 participants · First posted Aug 16, 2018

HER2 Vaccine for Locally Advanced Breast Cancer

36 participants · First posted Apr 29, 2025

Not yet recruiting

A Phase II Study of SSGJ-612 Plus a HER2-Targeted ADC in HR-Positive, HER2-Low or HER2-Ultralow Expression Metastatic Breast Cancer

87 participants · First posted Aug 11, 2026

Active, not recruiting

STOP-HER2: Stopping Trastuzumab in HER2+ MBC

82 participants · First posted Feb 9, 2023

Active, not recruiting

T Cells Expressing HER2-specific Chimeric Antigen Receptors(CAR) for Patients With HER2-Positive CNS Tumors

10 participants · First posted May 13, 2015

Page 1 of 381